Close

Immunomedics, Inc. (IMMU) Posts Q1 Loss of 10c/Share

May 8, 2012 4:02 PM EDT
Immunomedics, Inc. (NASDAQ: IMMU) reported Q1 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.2 million.

For earnings history and earnings-related data on Immunomedics, Inc. (IMMU) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings